Proof of Concept Study of ctDNA Guided Change in Treatment for Refractory Minimal Residual Disease in Colon Adenocarcinomas
Latest Information Update: 08 Mar 2024
At a glance
- Drugs Irinotecan (Primary) ; Tipiracil/trifluridine (Primary) ; Capecitabine; Fluorouracil
- Indications Adenocarcinoma; Colon cancer
- Focus Proof of concept; Therapeutic Use
- 01 Mar 2024 Planned End Date changed from 30 Jun 2024 to 31 Dec 2025.
- 01 Mar 2024 Planned primary completion date changed from 31 Dec 2023 to 31 Dec 2024.
- 09 Mar 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.